Literature DB >> 30288661

Disparities in Tdap Vaccination and Vaccine Information Needs Among Pregnant Women in the United States.

Jennifer L Kriss1, Alison P Albert2, Victoria M Carter3, Angela J Jiles2, Jennifer L Liang2, Jennifer Mullen3, Leslie Rodriguez3, Penelope P Howards4, Walter A Orenstein5, Saad B Omer6, Allison Fisher3.   

Abstract

Objectives The Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists (ACOG) recommend that pregnant women receive the Tdap vaccine during every pregnancy. The objectives of this paper are to evaluate disparities in Tdap vaccination among pregnant women in the U.S., and to assess whether race/ethnicity and other characteristics are associated with factors that inform pregnant women's decisions about Tdap vaccination. Methods We conducted a nationwide cross-sectional web-based survey of pregnant women in the U.S. during June-July 2014. The primary outcome was self-reported vaccination status with Tdap during pregnancy, categorized as vaccinated, unvaccinated with intent to be vaccinated during the current pregnancy, and unvaccinated with no intent to be vaccinated during the current pregnancy. Secondary outcomes included factors that influenced women's decisions about vaccination and information needs. We used multivariable logistic regression models to estimate odds ratios for associations between race/ethnicity and the outcomes. Results Among pregnant women who completed the survey, 41% (95% CI 36-45%) reported that they had received Tdap during the current pregnancy. Among those women in the third trimester at the time of survey, 52% (95% CI 43-60%) had received Tdap during the current pregnancy. Hispanic women had higher Tdap vaccination than white women and black women (53%, p < 0.05, compared with 38 and 36%, respectively). In logistic regression models adjusting for maternal age, geographic region, education, and income, Hispanic women were more likely to have been vaccinated with Tdap compared with white women (aOR 2.29, 95% CI 1.20-4.37). Higher income and residing in the western U.S. were also independently associated with Tdap vaccination during pregnancy. Twenty-six percent of surveyed women had not been vaccinated with Tdap yet but intended to receive the vaccine during the current pregnancy; this proportion did not differ significantly by race/ethnicity. The most common factor that influenced women to get vaccinated was a health care provider (HCP) recommendation. The most common reason for not getting vaccinated was a concern about safety of the vaccine. Conclusions This study found that some disparities exist in Tdap vaccination among pregnant women in the U.S., and HCPs have an important role in providing information and recommendations about the maternal Tdap recommendation to pregnant women so they can make informed vaccination decisions.

Entities:  

Keywords:  Pertussis; Pregnancy; Tdap; Vaccine; Whooping cough

Mesh:

Substances:

Year:  2019        PMID: 30288661     DOI: 10.1007/s10995-018-2633-8

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  7 in total

1.  Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.

Authors:  Mary Catherine Cambou; Timothy P Copeland; Karin Nielsen-Saines; James Macinko
Journal:  Vaccine       Date:  2021-03-18       Impact factor: 3.641

2.  Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.

Authors:  Irina Kolobova; Mawuli Kwame Nyaku; Anna Karakusevic; Daisy Bridge; Iain Fotheringham; Megan O'Brien
Journal:  Hum Vaccin Immunother       Date:  2022-05-10       Impact factor: 4.526

3.  Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination.

Authors:  Cornelia Betsch; Katrine Bach Habersaat; Sergei Deshevoi; Dorothee Heinemeier; Nikolay Briko; Natalia Kostenko; Janusz Kocik; Robert Böhm; Ingo Zettler; Charles Shey Wiysonge; Ève Dubé; Arnaud Gagneur; Elisabeth Botelho-Nevers; Amandine Gagneux-Brunon; Jonas Sivelä
Journal:  BMJ Open       Date:  2020-03-10       Impact factor: 2.692

4.  Increasing Uptake of Maternal Pertussis Vaccinations through Funded Administration in Community Pharmacies.

Authors:  Anna S Howe; Natalie J Gauld; Alana Y Cavadino; Helen Petousis-Harris; Felicity Dumble; Owen Sinclair; Cameron C Grant
Journal:  Vaccines (Basel)       Date:  2022-01-20

Review 5.  Understanding Information Needs and Barriers to Accessing Health Information Across All Stages of Pregnancy: Systematic Review.

Authors:  Yu Lu; Laura A Barrett; Rebecca Z Lin; Muhammad Amith; Cui Tao; Zhe He
Journal:  JMIR Pediatr Parent       Date:  2022-02-21

6.  Factors Influencing Maternal Antepartum Tdap Vaccination.

Authors:  Henry H Bernstein; Stephanie Tong-Miller; Shannon S Cleary; Margaret Sherin; Cathie Spino
Journal:  Matern Child Health J       Date:  2022-09-29

7.  Influences on Pregnant Women's and Health Care Professionals' Behaviour Regarding Maternal Vaccinations: A Qualitative Interview Study.

Authors:  Natalie Gauld; Samuel Martin; Owen Sinclair; Helen Petousis-Harris; Felicity Dumble; Cameron C Grant
Journal:  Vaccines (Basel)       Date:  2022-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.